Literature DB >> 7966085

An association of polymyalgia rheumatica with myelodysplastic syndromes.

M Kohli1, R M Bennett.   

Abstract

Myelodysplastic syndromes are a group of clonal hematopoietic stem cell disorders leading to peripheral cytopenias and a high probability of leukemic transformation. Immunological abnormalities, both humoral and cell mediated immunity, as well as vasculitis, a "lupus-like syndrome," neuropathy, and arthritis have been described in association with myelodysplastic syndromes. We describe 3 cases of polymyalgia rheumatica (PMR) developing within 4 months of detection of cytopenia. The possible association of myelodysplastic syndromes and PMR has not been previously recognized.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7966085

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  4 in total

Review 1.  Rheumatologic manifestations of benign and malignant haematological disorders.

Authors:  Vinod Ravindran; Parameswaran Anoop
Journal:  Clin Rheumatol       Date:  2011-06-23       Impact factor: 2.980

2.  Spondyloarthropathy presenting as a polymyalgia rheumatica-like syndrome.

Authors:  A Ponce; R Sanmarti; C Orellana; J Muñoz-Gomez
Journal:  Clin Rheumatol       Date:  1997-11       Impact factor: 2.980

3.  Paraneoplastic Large-vessel Vasculitis Associated with Myelodysplastic Syndrome.

Authors:  Hiroki Yabe
Journal:  Intern Med       Date:  2018-05-18       Impact factor: 1.271

Review 4.  Inflammatory arthritis in patients with myelodysplastic syndromes: a multicenter retrospective study and literature review of 68 cases.

Authors:  Arsène Mekinian; Thorsten Braun; Olivier Decaux; Géraldine Falgarone; Eric Toussirot; Loic Raffray; Mohamed Omouri; Bruno Gombert; Benoit De Wazieres; Anne-Laure Buchdaul; Jean-Marc Ziza; David Launay; Guillaume Denis; Serge Madaule; Christian Rose; Eric Grignano; Pierre Fenaux; Olivier Fain
Journal:  Medicine (Baltimore)       Date:  2014-01       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.